Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional analysis of ADARs in planarians supports a bilaterian ancestral role in suppressing double-stranded RNA-response. | PLoS Pathog | 2022 | 35041722 | PubTator, text mining | PubMed |
| Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome. | Mol Ther Nucleic Acids | 2022 | 35036070 | PubTator, text mining | PubMed |
| Suppression of RNA editing by miR-17 inhibits the stemness of melanoma stem cells. | Mol Ther Nucleic Acids | 2022 | 35036056 | PubTator, text mining | PubMed |
| Cytoplasmic RNA sensors and their interplay with RNA-binding partners in innate antiviral response: theme and variations. | RNA | 2022 | 35031583 | PubTator, text mining | PubMed |
| Phenotypic, trophic, and regenerative properties of mesenchymal stem cells from different osseous tissues. | Cell Tissue Res | 2022 | 35028747 | PubTator, text mining | PubMed |
| Testing of the therapeutic efficacy and safety of AMPA receptor RNA aptamers in an ALS mouse model. | Life Sci Alliance | 2022 | 35022247 | PubTator, text mining | PubMed |
| EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation. | Nat Commun | 2022 | 35013218 | PubTator, text mining | PubMed |
| Lung fibrosis is induced in ADAR2 overexpressing mice via HuR-induced CTGF signaling. | FASEB J | 2022 | 34985777 | PubTator, text mining | PubMed |
| Epigenetic modifications inhibit the expression of MARVELD1 and in turn tumorigenesis by regulating the Wnt/β-catenin pathway in pan-cancer. | J Cancer | 2022 | 34976185 | PubTator, text mining | PubMed |
| Chlorocholine chloride induced testosterone secretion inhibition mediated by endoplasmic reticulum stress in primary rat Leydig cells. | Toxicol Lett | 2022 | 34958886 | PubTator, text mining | PubMed |
| Drug delivery approaches for HuR-targeted therapy for lung cancer. | Adv Drug Deliv Rev | 2022 | 34822926 | PubTator, text mining | PubMed |
| Cellular origins of dsRNA, their recognition and consequences. | Nat Rev Mol Cell Biol | 2022 | 34815573 | PubTator, text mining | PubMed |
| Epitranscriptomics of cardiovascular diseases (Review). | Int J Mol Med | 2022 | 34791505 | PubTator, text mining | PubMed |
| CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review. | Mol Biotechnol | 2022 | 34741732 | PubTator, text mining | PubMed |
| Lessons learnt from multifaceted diagnostic approaches to the first 150 families in Victoria's Undiagnosed Diseases Program. | J Med Genet | 2022 | 34740920 | PubTator, text mining | PubMed |
| Targeted RNA editing: novel tools to study post-transcriptional regulation. | Mol Cell | 2022 | 34739873 | PubTator, text mining | PubMed |
| Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases. | Mol Neurobiol | 2022 | 34655056 | PubTator, text mining | PubMed |
| Compact RNA editors with small Cas13 proteins. | Nat Biotechnol | 2022 | 34462587 | PubTator, text mining | PubMed |
| ADAR2 increases in exercised heart and protects against myocardial infarction and doxorubicin-induced cardiotoxicity. | Mol Ther | 2022 | 34274534 | PubTator, text mining | PubMed |
| Epitranscriptomic Modifications Modulate Normal and Pathological Functions in CNS. | Transl Stroke Res | 2022 | 34224107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=26